SELLAS Life Sciences Group annual free cash flow
2010
2011
2013
2014
2015
2016
2022
2023
SELLAS Life Sciences Group Free Cash Flow (FCF) History (SLS)
SELLAS Life Sciences Group reported −$36.9M in free cash flow for fiscal 2023, a decrease of $8.6M from the previous fiscal year.
View full SELLAS Life Sciences Group company overviewSELLAS Life Sciences Group free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2023 | 2023-12-31 | −$36.9M | −$8.6M | — | — |
| 2022 | 2022-12-31 | −$28.3M | — | — | −2830.90% |
| 2016 | 2016-12-31 | −$11.9M | $36.5M | — | — |
| 2015 | 2015-12-31 | −$48.3M | −$5.4M | — | — |
| 2014 | 2014-12-31 | −$42.9M | −$13.7M | — | −460.63% |
| 2013 | 2013-12-31 | −$29.2M | — | — | −1176.08% |
| 2011 | 2011-12-31 | −$14.7M | −$4.4M | — | — |
| 2010 | 2010-12-31 | −$10.4M | — | — | — |
SELLAS Life Sciences Group quarterly free cash flow
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q3.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2016 | 2016-12-31 | $25.1M | $40.4M | — | — |
| Q3 2016 | 2016-09-30 | −$12.2M | −$2.7M | — | — |
| Q2 2016 | 2016-06-30 | −$11.5M | $385,000 | — | — |
| Q1 2016 | 2016-03-31 | −$13.2M | −$1.6M | — | — |
| Q4 2015 | 2015-12-31 | −$15.4M | −$4.6M | — | — |
| Q3 2015 | 2015-09-30 | −$9.5M | $1.6M | — | — |
| Q2 2015 | 2015-06-30 | −$11.9M | $1.1M | — | −351.15% |
| Q1 2015 | 2015-03-31 | −$11.6M | −$3.5M | — | −420.87% |
| Q4 2014 | 2014-12-31 | −$10.7M | — | — | −336.24% |
| Q3 2014 | 2014-09-30 | −$11.1M | −$3.0M | — | −687.28% |
| Q2 2014 | 2014-06-30 | −$13.0M | — | — | −556.80% |
| Q1 2014 | 2014-03-31 | −$8.1M | — | — | −371.38% |
| Q3 2013 | 2013-09-30 | −$8.1M | — | — | −373.36% |
| Q4 2011 | 2011-12-31 | −$4.2M | — | — | — |
| Q3 2011 | 2011-09-30 | −$3.4M | −$1.2M | — | — |
| Q2 2011 | 2011-06-30 | −$4.1M | — | — | — |
| Q1 2011 | 2011-03-31 | −$3.1M | — | — | — |
| Q3 2010 | 2010-09-30 | −$2.2M | — | — | — |
SELLAS Life Sciences Group free cash flow growth trends
SELLAS Life Sciences Group's latest reported quarter, Q4 2016, generated $25.1M in free cash flow, an increase of $40.4M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review SELLAS Life Sciences Group source filings ↗